Alligator Bioscience Financials
| ATORX Stock | SEK 0.56 0.01 1.82% |
Alligator |
Understanding current and past Alligator Bioscience Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Alligator Bioscience's financial statements are interrelated, with each one affecting the others. For example, an increase in Alligator Bioscience's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Alligator Bioscience's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Alligator Bioscience AB. Check Alligator Bioscience's Beneish M Score to see the likelihood of Alligator Bioscience's management manipulating its earnings.
Alligator Bioscience Stock Summary
Alligator Bioscience competes with Cantargia, BioArctic, Oncopeptides, Hansa Biopharma, and BioInvent International. Alligator Bioscience AB develops antibody-based pharmaceuticals for cancer treatment. Alligator Bioscience AB was founded in 2001 and is headquartered in Lund, Sweden. Alligator Bioscience operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 56 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0000767188 |
| Business Address | Medicon Village, Lund, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.alligatorbioscience.se |
| Phone | 46 4 65 40 82 00 |
| Currency | SEK - Swedish Kronor |
You should never invest in Alligator Bioscience without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Alligator Stock, because this is throwing your money away. Analyzing the key information contained in Alligator Bioscience's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Alligator Bioscience Key Financial Ratios
There are many critical financial ratios that Alligator Bioscience's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Alligator Bioscience reports annually and quarterly.Alligator Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alligator Bioscience's current stock value. Our valuation model uses many indicators to compare Alligator Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alligator Bioscience competition to find correlations between indicators driving Alligator Bioscience's intrinsic value. More Info.Alligator Bioscience AB is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alligator Bioscience's earnings, one of the primary drivers of an investment's value.Alligator Bioscience Systematic Risk
Alligator Bioscience's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Alligator Bioscience volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Alligator Bioscience correlated with the market. If Beta is less than 0 Alligator Bioscience generally moves in the opposite direction as compared to the market. If Alligator Bioscience Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Alligator Bioscience is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Alligator Bioscience is generally in the same direction as the market. If Beta > 1 Alligator Bioscience moves generally in the same direction as, but more than the movement of the benchmark.
Alligator Bioscience December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Alligator Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alligator Bioscience AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alligator Bioscience AB based on widely used predictive technical indicators. In general, we focus on analyzing Alligator Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alligator Bioscience's daily price indicators and compare them against related drivers.
| Information Ratio | (0.23) | |||
| Maximum Drawdown | 31.42 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 4.29 |
Additional Tools for Alligator Stock Analysis
When running Alligator Bioscience's price analysis, check to measure Alligator Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alligator Bioscience is operating at the current time. Most of Alligator Bioscience's value examination focuses on studying past and present price action to predict the probability of Alligator Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alligator Bioscience's price. Additionally, you may evaluate how the addition of Alligator Bioscience to your portfolios can decrease your overall portfolio volatility.